论文部分内容阅读
治疗组及对照组各30例,均以口服肌苷,维生素B、C及酌情滴注葡萄糖液为基础治疗。治疗组给予静输注胎肝细胞悬液,每次输入有核细胞1.97×10~9～6×10~9。治疗2～10次,间隔3～10天输1次,治疗3个月。结果:ALT复常日数治疗组明显短于对照组。治疗组基本治愈24例,好转3例,无变化3例;对照组分别为16、6及8例。近期治愈率分别为80％及54.3％(P<0.05)。治疗组随
The treatment group and the control group of 30 cases, all oral inosine, vitamin B, C and, as appropriate, infusion of glucose solution-based treatment. The treatment group was given intravenous infusion of fetal liver cell suspension, each input of nucleated cells 1.97 × 10 ~ 9 ~ 6 × 10 ~ 9. Treatment of 2 to 10 times, an interval of 3 to 10 days lost 1, 3 months of treatment. Results: ALT recovery days were significantly shorter in the treatment group than in the control group. The treatment group was basically cured in 24 cases, improved in 3 cases, no change in 3 cases; control group were 16,6 and 8 cases. The recent cure rates were 80% and 54.3% (P <0.05). Treatment group with